Personalized Symptom Goals and Patient Global Impression on Clinical Changes in Advanced Cancer Patients

Sebastiano Mercadante, Claudio Adile, Gaetano Lanzetta, Kyriaki Mystakidou, Marco Maltoni, Luiz Guilherme Soares, Stefano De Santis, Patrizia Ferrera, Marco Valenti, Marta Rosati, Romina Rossi, Andrea Cortegiani, Francesco Masedu, Franco Marinangeli, Federica Aielli

Research output: Contribution to journalArticle

Abstract

Background: The aim of this study was to assess the patients' global impression (PGI) after symptom management, as well as the achievement of personalized symptom goals (PSG). The secondary outcome was to assess related factors. Subjects, Materials, and Methods. Advanced cancer patients admitted to palliative care units rated symptom intensity by using the Edmonton Symptom Assessment Score (ESAS) at admission and then after 1 week. For each symptom, patient-reported PGI and PSG, as well as the rate of PSG response, were evaluated. Results: Eight hundred seventy-six patients were taken into consideration for this study. A mean of 1.71-2.16 points was necessary to perceive a bit better improvement of symptom intensity. Most patients had a PSG of ≤3. A statistically significant number of patients achieved their PSG after starting palliative care. Patients with high intensity of ESAS items at admission achieved a more favorable PGI response. In the multivariate analysis, symptom intensity and PSG were the most frequent factors independently associated to a best PGI, whereas high levels of Karnofsky had a lower odd ratio. Conclusion: PSG and PGI seem to be relevant for patients' assessment and decision-making process, translating in terms of therapeutic intervention. Some factors may be implicated in determining the individual target and clinical response. Implications for Practice: Personalized symptom goals and global impression of change are relevant for patients' assessment and decision-making process, translating in terms of therapeutic intervention. Some factors may be implicated in determining the individual target and clinical response.

Original languageEnglish
JournalOncologist
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Neoplasms
Symptom Assessment
Palliative Care
Decision Making
Multivariate Analysis
Odds Ratio
Therapeutics

Keywords

  • Advanced cancer
  • Global impression of change
  • Palliative care
  • Personalized symptom goal
  • Symptom assessment

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Personalized Symptom Goals and Patient Global Impression on Clinical Changes in Advanced Cancer Patients. / Mercadante, Sebastiano; Adile, Claudio; Lanzetta, Gaetano; Mystakidou, Kyriaki; Maltoni, Marco; Soares, Luiz Guilherme; De Santis, Stefano; Ferrera, Patrizia; Valenti, Marco; Rosati, Marta; Rossi, Romina; Cortegiani, Andrea; Masedu, Francesco; Marinangeli, Franco; Aielli, Federica.

In: Oncologist, 01.01.2018.

Research output: Contribution to journalArticle

Mercadante, S, Adile, C, Lanzetta, G, Mystakidou, K, Maltoni, M, Soares, LG, De Santis, S, Ferrera, P, Valenti, M, Rosati, M, Rossi, R, Cortegiani, A, Masedu, F, Marinangeli, F & Aielli, F 2018, 'Personalized Symptom Goals and Patient Global Impression on Clinical Changes in Advanced Cancer Patients', Oncologist. https://doi.org/10.1634/theoncologist.2017-0668
Mercadante, Sebastiano ; Adile, Claudio ; Lanzetta, Gaetano ; Mystakidou, Kyriaki ; Maltoni, Marco ; Soares, Luiz Guilherme ; De Santis, Stefano ; Ferrera, Patrizia ; Valenti, Marco ; Rosati, Marta ; Rossi, Romina ; Cortegiani, Andrea ; Masedu, Francesco ; Marinangeli, Franco ; Aielli, Federica. / Personalized Symptom Goals and Patient Global Impression on Clinical Changes in Advanced Cancer Patients. In: Oncologist. 2018.
@article{1fe88b0e6216413d91982575b3bbe149,
title = "Personalized Symptom Goals and Patient Global Impression on Clinical Changes in Advanced Cancer Patients",
abstract = "Background: The aim of this study was to assess the patients' global impression (PGI) after symptom management, as well as the achievement of personalized symptom goals (PSG). The secondary outcome was to assess related factors. Subjects, Materials, and Methods. Advanced cancer patients admitted to palliative care units rated symptom intensity by using the Edmonton Symptom Assessment Score (ESAS) at admission and then after 1 week. For each symptom, patient-reported PGI and PSG, as well as the rate of PSG response, were evaluated. Results: Eight hundred seventy-six patients were taken into consideration for this study. A mean of 1.71-2.16 points was necessary to perceive a bit better improvement of symptom intensity. Most patients had a PSG of ≤3. A statistically significant number of patients achieved their PSG after starting palliative care. Patients with high intensity of ESAS items at admission achieved a more favorable PGI response. In the multivariate analysis, symptom intensity and PSG were the most frequent factors independently associated to a best PGI, whereas high levels of Karnofsky had a lower odd ratio. Conclusion: PSG and PGI seem to be relevant for patients' assessment and decision-making process, translating in terms of therapeutic intervention. Some factors may be implicated in determining the individual target and clinical response. Implications for Practice: Personalized symptom goals and global impression of change are relevant for patients' assessment and decision-making process, translating in terms of therapeutic intervention. Some factors may be implicated in determining the individual target and clinical response.",
keywords = "Advanced cancer, Global impression of change, Palliative care, Personalized symptom goal, Symptom assessment",
author = "Sebastiano Mercadante and Claudio Adile and Gaetano Lanzetta and Kyriaki Mystakidou and Marco Maltoni and Soares, {Luiz Guilherme} and {De Santis}, Stefano and Patrizia Ferrera and Marco Valenti and Marta Rosati and Romina Rossi and Andrea Cortegiani and Francesco Masedu and Franco Marinangeli and Federica Aielli",
year = "2018",
month = "1",
day = "1",
doi = "10.1634/theoncologist.2017-0668",
language = "English",
journal = "Oncologist",
issn = "1083-7159",
publisher = "Wiley Blackwell",

}

TY - JOUR

T1 - Personalized Symptom Goals and Patient Global Impression on Clinical Changes in Advanced Cancer Patients

AU - Mercadante, Sebastiano

AU - Adile, Claudio

AU - Lanzetta, Gaetano

AU - Mystakidou, Kyriaki

AU - Maltoni, Marco

AU - Soares, Luiz Guilherme

AU - De Santis, Stefano

AU - Ferrera, Patrizia

AU - Valenti, Marco

AU - Rosati, Marta

AU - Rossi, Romina

AU - Cortegiani, Andrea

AU - Masedu, Francesco

AU - Marinangeli, Franco

AU - Aielli, Federica

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: The aim of this study was to assess the patients' global impression (PGI) after symptom management, as well as the achievement of personalized symptom goals (PSG). The secondary outcome was to assess related factors. Subjects, Materials, and Methods. Advanced cancer patients admitted to palliative care units rated symptom intensity by using the Edmonton Symptom Assessment Score (ESAS) at admission and then after 1 week. For each symptom, patient-reported PGI and PSG, as well as the rate of PSG response, were evaluated. Results: Eight hundred seventy-six patients were taken into consideration for this study. A mean of 1.71-2.16 points was necessary to perceive a bit better improvement of symptom intensity. Most patients had a PSG of ≤3. A statistically significant number of patients achieved their PSG after starting palliative care. Patients with high intensity of ESAS items at admission achieved a more favorable PGI response. In the multivariate analysis, symptom intensity and PSG were the most frequent factors independently associated to a best PGI, whereas high levels of Karnofsky had a lower odd ratio. Conclusion: PSG and PGI seem to be relevant for patients' assessment and decision-making process, translating in terms of therapeutic intervention. Some factors may be implicated in determining the individual target and clinical response. Implications for Practice: Personalized symptom goals and global impression of change are relevant for patients' assessment and decision-making process, translating in terms of therapeutic intervention. Some factors may be implicated in determining the individual target and clinical response.

AB - Background: The aim of this study was to assess the patients' global impression (PGI) after symptom management, as well as the achievement of personalized symptom goals (PSG). The secondary outcome was to assess related factors. Subjects, Materials, and Methods. Advanced cancer patients admitted to palliative care units rated symptom intensity by using the Edmonton Symptom Assessment Score (ESAS) at admission and then after 1 week. For each symptom, patient-reported PGI and PSG, as well as the rate of PSG response, were evaluated. Results: Eight hundred seventy-six patients were taken into consideration for this study. A mean of 1.71-2.16 points was necessary to perceive a bit better improvement of symptom intensity. Most patients had a PSG of ≤3. A statistically significant number of patients achieved their PSG after starting palliative care. Patients with high intensity of ESAS items at admission achieved a more favorable PGI response. In the multivariate analysis, symptom intensity and PSG were the most frequent factors independently associated to a best PGI, whereas high levels of Karnofsky had a lower odd ratio. Conclusion: PSG and PGI seem to be relevant for patients' assessment and decision-making process, translating in terms of therapeutic intervention. Some factors may be implicated in determining the individual target and clinical response. Implications for Practice: Personalized symptom goals and global impression of change are relevant for patients' assessment and decision-making process, translating in terms of therapeutic intervention. Some factors may be implicated in determining the individual target and clinical response.

KW - Advanced cancer

KW - Global impression of change

KW - Palliative care

KW - Personalized symptom goal

KW - Symptom assessment

UR - http://www.scopus.com/inward/record.url?scp=85047666285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047666285&partnerID=8YFLogxK

U2 - 10.1634/theoncologist.2017-0668

DO - 10.1634/theoncologist.2017-0668

M3 - Article

AN - SCOPUS:85047666285

JO - Oncologist

JF - Oncologist

SN - 1083-7159

ER -